Current discharge management of acute coronary syndromes: baseline results from a national quality improvement initiative

被引:14
|
作者
Wai, A. [1 ]
Pulver, L. K. [3 ]
Oliver, K. [2 ]
Thompson, A. [4 ]
机构
[1] Natl Prescribing Serv Ltd, Sydney, NSW 2012, Australia
[2] New S Wales Therapeut Advisory Grp, Darlinghurst, NSW, Australia
[3] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
[4] Univ Tasmania, Tasmanian Sch Pharm, Hobart, Tas, Australia
关键词
acute coronary syndromes; patient discharge; drug utilisation review; evidence-based medicine; CARDIAC REHABILITATION; PROGRAM; DISEASE; GUIDELINES; AUSTRALIA; IMPACT; RISK; CARE;
D O I
10.1111/j.1445-5994.2010.02308.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Evidencepractice gaps exist in the continuum of care for patients with acute coronary syndromes (ACS), particularly at hospital discharge. Aim: We aimed to describe the methodology and baseline results of the Discharge Management of Acute Coronary Syndromes (DMACS) project, focusing on the prescription of guideline-recommended medications, referral to cardiac rehabilitation and communication between the hospital, patient and their primary healthcare professionals. Methods: DMACS employed Drug Use Evaluation methodology involving data collection, evaluation and feedback, and targeted educational interventions. Adult patients with ACS discharged during a 4-month period were eligible to participate. Data were collected (maximum 50 patients) at each site through an inpatient medical record review, a general practitioner (GP) postal/fax survey conducted 14 days post discharge and a patient telephone survey 3 months post discharge. Results: Forty-nine hospitals participated in the audit recruiting 1545 patients. At discharge, 57% of patients were prescribed a combination of antiplatelet agent(s), beta-blocker, statin and angiotensin-converting enzyme inhibitor and/or angiotensin II-antagonist. At 3 months post discharge, 48% of patients reported using the same combination. Some 67% of patients recalled being referred to cardiac rehabilitation; of these, 33% had completed the programme. In total, 83% of patients had a documented ACS management plan at discharge. Of these, 90% included a medication list, 56% a chest pain action plan and 54% risk factor modification advice. Overall, 65% of GPs rated the quality of information received in the discharge summary as very good to excellent. Conclusions: The findings of our baseline audit showed that despite the robust evidence base and availability of national guidelines, the management of patients with ACS can be improved. These findings will inform a multifaceted intervention strategy to improve adherence to guidelines for the discharge management of patients with ACS.
引用
收藏
页码:e53 / e59
页数:7
相关论文
共 50 条
  • [31] Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico: The Third National Registry of Acute Coronary Syndromes (RENASICA III)
    Martinez-Sanchez, Carlos
    Borrayo, Gabriela
    Carrillo, Jorge
    Juarez, Ursulo
    Quintanilla, Juan
    Jerjes-Sanchez, Carlos
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2016, 86 (03): : 221 - 232
  • [32] Influence of the new definition of acute myocardial infarction on coronary care unit admission, discharge diagnosis, management and outcome in patients with non-ST elevation acute coronary syndromes: A national survey
    Zahger, D
    Hod, H
    Gottlieb, S
    Leor, J
    Hasdai, D
    Sandach, A
    Hammerman, H
    Behar, S
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 106 (02) : 164 - 169
  • [33] Predictors of discharge to home following major surgery for urologic malignancies: Results from the national surgical quality improvement program
    Aihie, Nehizena S.
    Hougen, Helen Y.
    Kwon, Deukwoo
    Punnen, Sanoj
    Nahar, Bruno
    Parekh, Dipen J.
    Gonzalgo, Mark L.
    Ritch, Chad R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 392.e19 - 392.e25
  • [34] Are the Benefits of Quality-of-Care Improvement Programs in Acute Coronary Syndromes Maintained Once the Intervention Is Over?
    Barrabes, Jose
    Galian, Laura
    Rueda, Ferran
    Nieto, Elsa
    Figueras, Jaume
    Cortadellas, Josefa
    Lidon, Rosa-Maria
    Garcia-Dorado, David
    CIRCULATION, 2010, 122 (21)
  • [35] From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes
    Tan, Nigel S.
    Yan, Andrew T.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (25) : 3790 - 3801
  • [36] Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
    Ronco, Claudio
    McCullough, Peter A.
    Anker, Stefan D.
    Anand, Inder
    Aspromonte, Nadia
    Bagshaw, Sean M.
    Bellomo, Rinaldo
    Berl, Tomas
    Bobek, Ilona
    Cruz, Dinna N.
    Daliento, Luciano
    Davenport, Andrew
    Haapio, Mikko
    Hillege, Hans
    House, Andrew
    Katz, Nevin M.
    Maisel, Alan
    Mankad, Sunil
    Zanco, Pierluigi
    Mebazaa, Alexandre
    Palazzuoli, Alberto
    Ronco, Federico
    Shaw, Andrew
    Sheinfeld, Geoff
    Soni, Sachin
    Vescovo, Giorgio
    Zamperetti, Nereo
    Ponikowski, Piotr
    CARDIORENAL SYNDROMES IN CRITICAL CARE, 2010, 165 : 54 - 67
  • [37] Factors Associated With Medical Staff's Engagement and Perception of a Quality Improvement Program for Acute Coronary Syndromes in Hospitals: A Nationally Representative Mixed-Methods Study in China
    Zhou, Shuduo
    Jin, Yinzi
    Ma, Junxiong
    Dong, Xuejie
    Li, Na
    Shi, Hong
    Zhang, Yan
    Guan, Xiaoyu
    LaBresh, Kenneth A.
    Smith, Sidney C., Jr.
    Huo, Yong
    Zheng, Zhi-Jie
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (07):
  • [38] Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes - results from the BASKET PROVE trial
    Jensen, Magnus Thorsten
    Kaiser, Christoph
    Sandsten, Karl Erik
    Alber, Hannes
    Wanitschek, Maria
    Iversen, Allan
    Jensen, Jan Skov
    Pedersen, Sune
    Soerensen, Rikke
    Rickli, Hans
    Zurek, Marzena
    Fahrni, Gregor
    Bertel, Osmund
    De Servi, Stefano
    Erne, Paul
    Pfisterer, Matthias
    Galatius, Soren
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 3802 - 3806
  • [39] The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial
    Meier, Pascal
    Lansky, Alexandra J.
    Fahy, Martin
    Xu, Ke
    White, Harvey D.
    Bertrand, Michel E.
    Mehran, Roxana
    Stone, Gregg W.
    HEART, 2014, 100 (08) : 647 - 651
  • [40] Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial
    Wu, Yangfeng
    Li, Shenshen
    Patel, Anushka
    Li, Xian
    Du, Xin
    Wu, Tao
    Zhao, Yifei
    Feng, Lin
    Billot, Laurent
    Peterson, Eric D.
    Woodward, Mark
    Kong, Lingzhi
    Huo, Yong
    Hu, Dayi
    Chalkidou, Kalipso
    Gao, Runlin
    Chalkidou, Kalipso
    Gao, Runlin
    Hu, Dayi
    Huo, Yong
    Jiao, Yahui
    Kong, Lingzhi
    Patel, Anushka
    Peterson, Eric
    Turnbull, Fiona
    Woodward, Mark
    Wu, Yangfeng
    Chen, Yu
    Li, Chun
    Shen, Ming
    Sun, Yihong
    Xi, Yang
    Zhou, Danbing
    Wang, Guiying
    Xu, Shan
    Sang, Tongbao
    Song, Dongxue
    Sun, Lijuan
    Bai, Shuying
    Li, Helan
    Zhang, Jinrong
    Hu, Shaoyong
    Ma, Hecai
    Li, Yuezhou
    Liu, Wenli
    Xiao, Lijing
    Yang, Yuwang
    Luo, Yuhui
    Yu, Tianming
    Guo, Huanyu
    JAMA CARDIOLOGY, 2019, 4 (05) : 418 - 427